Achieve Life Sciences Inc.

+0.16 (+2.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)64.00M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.06 Million
Adjusted EPS-$0.81
See more estimates
10-Day MA$6.74
50-Day MA$7.24
200-Day MA$7.63
See more pivots

Achieve Life Sciences Inc. Stock, NASDAQ:ACHV

1040 West Georgia Street, Suite 1030, Vancouver, British Columbia V6E 4H1
United States of America
Phone: +1.604.210.2217
Number of Employees: 16


Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.